Takeda Pharmaceutical
TAK
#452
Rank
A$78.54 B
Marketcap
A$24.59
Share price
1.06%
Change (1 day)
11.64%
Change (1 year)

Takeda Pharmaceutical (TAK) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$72.73 Billion

According to Takeda Pharmaceutical's latest financial reports the company's total liabilities are A$72.73 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Takeda Pharmaceutical - Total liabilities on balance sheet (from 2008 to 2026)

Total liabilities by year

Year Total liabilities Change
2026-03-31A$73.63 B-5.77%
2025-03-31A$78.14 B-1.35%
2024-03-31A$79.21 B-6.96%
2023-03-31A$85.13 B3.62%
2022-03-31A$82.15 B-10.67%
2021-03-31A$91.97 B-25.03%
2020-03-31A$122.67 B12.54%
2019-03-31A$109.00 B326.18%
2018-03-31A$25.57 B-9.26%
2017-03-31A$28.18 B34.13%
2016-03-31A$21.01 B-8.12%
2015-03-31A$22.87 B7.86%
2014-03-31A$21.20 B21.43%
2013-03-31A$17.46 B4.43%
2012-03-31A$16.72 B121.7%
2011-03-31A$7.54 B-1.04%
2010-03-31A$7.62 B-25.59%
2009-03-31A$10.24 B83.19%
2008-03-31A$5.59 B-12.99%
2007-03-31A$6.42 B-23%
2006-03-31A$8.34 B27.62%
2005-03-31A$6.53 B-7.85%
2004-03-31A$7.09 B2.56%
2003-03-31A$6.91 B-9.72%
2002-03-31A$7.66 B-5.75%
2001-03-31A$8.13 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$170.87 B 134.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$113.62 B 56.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$167.31 B 130.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$118.92 B 63.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$90.66 B 24.65%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$118.12 B 62.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$85.91 B 18.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
A$1.54 B-97.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
A$3.03 B-95.82%๐Ÿ‡ฎ๐Ÿ‡ณ India